Obling, Laust E. R. http://orcid.org/0000-0003-2927-3670
Beske, Rasmus P.
Meyer, Martin A. S.
Grand, Johannes
Wiberg, Sebastian
Nyholm, Benjamin
Josiassen, Jakob
Søndergaard, Frederik T.
Mohr, Thomas
Damm-Hejmdal, Anders
Bjerre, Mette
Frikke-Schmidt, Ruth
Folke, Fredrik
Møller, Jacob E.
Kjaergaard, Jesper
Hassager, Christian
Clinical trials referenced in this document:
Documents that mention this clinical trial
Prehospital high-dose methylprednisolone in resuscitated out-of-hospital cardiac arrest patients (STEROHCA): a randomized clinical trial
https://doi.org/10.1007/s00134-023-07247-w
Funding for this research was provided by:
Novo Nordisk Fonden (NNF20OC0064043)
Royal Library, Copenhagen University Library
Article History
Received: 13 September 2023
Accepted: 4 October 2023
First Online: 9 November 2023
Declarations
:
: The salary of the corresponding author was supported by a grant from the Research Foundation of Rigshospitalet (E-22652-04). The study, inclusive salary of RPB, was supported by a grant from Novo Nordisk Foundation (NNF20OC0064043) in the name of CH. CH is also supported by an unrestricted grant from Lundbeck Foundation (R186-2015–2132), and received a speaker honorarium from Abiomed during the course of the study, and further is a board member of the European Society of Cardiology and serves as chair of the Danish Heart Foundation. JK is supported by an unrestricted grant from Novo Nordisk Foundation (NNF17OC0028706), and is a part of two Data Safety Monitoring Boards for two randomized controlled trials, The IVIO trial (chair) and the COCA trial, without any reimbursement. JEM received two research grants outside the current study from Abiomed and Novo Nordisk Foundation; further he received speaker honorariums from Abiomed, Abbott, and Boehringer Ingelheim, and attended meetings with the support of Abiomed. FF is supported by a research grant from Novo Nordisk Foundation (NNF19OC0055142). RFS received grants from Lundbeck Foundation, Danish Heart Foundation, and Sygeforsikringen Danmark Research Fund, all outside the current study. The remaining authors have nothing to disclose.
: Prior to initiation of the trial, permissions were obtained from the Regional Ethics Committee (ID: H-20022320) and the Danish Medicines Agency (ID: 2020033425), and a legal data handling agreement was approved by the Capital Region of Denmark (ID: P-2020–866).
: The trial was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from a primary trial guardian before inclusion and subsequently confirmed by a secondary trial guardian. Written informed consent from the nearest relatives was obtained as soon as possible following admission to the hospital and further from all patients upon regained capacity.